Heparin-like glycosaminoglycans prevent the infection of measles virus in SLAM-negative cell lines

Antiviral Research

Volumn 80, Issue 3, 2008, Pages 370-376

  Terao Muto, Yuri ^a   Yoneda, Misako ^a   Seki, Takahiro ^a   Watanabe, Akira ^a   Tsukiyama Kohara, Kyoko ^a   Fujita, Kentaro ^a   Kai, Chieko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Hemagglutinin; Heparan sulphate; Measles virus; SLAM negative cells

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; GLYCOSAMINOGLYCAN; HEPARIN DERIVATIVE; HYBRID PROTEIN; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL LINE; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFECTION PREVENTION; LYMPHOCYTE ACTIVATION; MEASLES; MEASLES VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; SURFACE PLASMON RESONANCE; VIRION; VIRUS ATTACHMENT; VIRUS INHIBITION; VIRUS RECOMBINANT; VIRUS REPLICATION;

ANTIGENS, CD; CELL LINE; GLYCOSAMINOGLYCANS; GREEN FLUORESCENT PROTEINS; HEMAGGLUTININS, VIRAL; HEPARIN; HUMANS; MEASLES; MEASLES VIRUS; PROTEIN BINDING; RECEPTORS, CELL SURFACE; RECEPTORS, VIRUS; RECOMBINANT FUSION PROTEINS; VIRAL FUSION PROTEINS; VIRUS INTERNALIZATION;

MEASLES VIRUS; MORBILLIVIRUS;

EID: 56349124125     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2008.08.006     Document Type: Article

References (26)

1. Andres O., Obojes K., Kim K.S., ter Meulen V., and Schneider-Schaulies J. CD46- and CD150-independent endothelial cell infection with wild-type measles viruses. J. Gen. Virol. 84 (2003) 1189-1197
2. Baron M.D. Wild-type Rinderpest virus uses SLAM (CD150) as its receptor. J. Gen. Virol. 86 (2005) 1753-1757
3. Baron M.D., and Barrett T. Rescue of rinderpest virus from cloned cDNA. J. Virol. 71 (1997) 1265-1271
4. Cocks B.G., Chang C.C., Carballido J.M., Yssel H., de Vries J.E., and Aversa G. A novel receptor involved in T-cell activation. Nature 376 (1995) 260-263
5. de Witte L., Abt M., Schneider-Schaulies S., van Kooyk Y., and Geijtenbeek T.B. Measles virus targets DC-SIGN to enhance dendritic cell infection. J. Virol. 80 (2006) 3477-3486
6. DeAngelis P.L. Microbial glycosaminoglycan glycosyltransferases. Glycobiology 12 (2002) 9R-16R
7. Dörig R.E., Marcil A., Chopra A., and Richardson C.D. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 75 (1993) 295-305
8. Feldman S.A., Audet S., and Beeler J.A. The fusion glycoprotein of human respiratory syncytial virus facilitates virus attachment and infectivity via an interaction with cellular heparan sulfate. J. Virol. 74 (2000) 6442-6447
9. Fujita K., Miura R., Yoneda M., Shimizu F., Sato H., Muto Y., Endo Y., Tsukiyama-Kohara K., and Kai C. Host range and receptor utilization of canine distemper virus analyzed by recombinant viruses: involvement of heparin-like molecule in CDV infection. Virology 359 (2007) 324-335
10. Griffin D.E. Measles virus. Fields Virology. 5th ed. (2007) pp. 1551-1585
11. Hashimoto K., Ono N., Tatsuo H., Minagawa H., Takeda M., Takeuchi K., and Yanagi Y. SLAM (CD150)-independent measles virus entry as revealed by recombinant virus expressing green fluorescent protein. J. Virol. 76 (2002) 6743-6749
12. Jackson R.L., Busch S.J., and Cardin A.D. Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes. Physiol. Rev. 71 (1991) 481-539
13. Jacobsson I., and Lindahl U. Biosynthesis of heparin. Concerted action of late polymer-modification reactions. J. Biol. Chem. 255 (1980) 5094-5100
14. Kobune F., Sakata H., and Sugiura A. Marmoset lymphoblastoid cells as a sensitive host for isolation of measles virus. J. Virol. 64 (1990) 700-705
15. Lee E., Pavy M., Young N., Freeman C., and Lobigs M. Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses. Antiviral Res. 69 (2006) 31-38
16. Lindahl U., and Kjellén L. Heparin or heparan sulfate-what is the difference?. Thromb. Haemost. 66 (1991) 44-48
17. Naniche D., Varior-Krishnan G., Cervoni F., Wild T.F., Rossi B., Rabourdin-Combe C., and Gerlier D. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J. Virol. 67 (1993) 6025-6032
18. Ono N., Tatsuo H., Hidaka Y., Aoki T., Minagawa H., and Yanagi Y. Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor. J. Virol. 75 (2001) 4399-4401
19. Radecke F., Spielhofer P., Schneider H., Kaelin K., Huber M., Dötsch C., Christiansen G., and Billeter M.A. Rescue of measles viruses from cloned DNA. EMBO J. 14 (1995) 5773-5784
20. Sato H., Honma R., Yoneda M., Miura R., Tsukiyama-Kohara K., Ikeda F., Seki T., Watanabe S., and Kai C. Measles virus induces cell-type specific changes in gene expression. Virology 375 (2008) 321-330
21. Tahara M., Takeda M., Shirogane Y., Hashiguchi T., Ohno S., and Yanagi Y. Measles virus infects both polarized epithelial and immune cells by using distinctive receptor-binding sites on its hemagglutinin. J. Virol. 82 (2008) 4630-4637
22. Takeda M., Tahara M., Hashiguchi T., Sato T.A., Jinnouchi F., Ueki S., Ohno S., and Yanagi Y. A human lung carcinoma cell line supports efficient measles virus growth and syncytium formation via a SLAM- and CD46-independent mechanism. J. Virol. 81 (2007) 12091-12096
23. Takeuchi K., Miyajima N., Nagata N., Takeda M., and Tashiro M. Wild-type measles virus induces large syncytium formation in primary human small airway epithelial cells by a SLAM (CD150)-independent mechanism. Virus Res. 94 (2003) 11-16
24. Tatsuo H., Ono N., Tanaka K., and Yanagi Y. SLAM (CDw150) is a cellular receptor for measles virus. Nature 406 (2000) 893-897
25. Vogt A.M., Barragan A., Chen Q., Kironde F., Spillmann D., and Wahlgren M. Heparan sulfate on endothelial cells mediates the binding of Plasmodium falciparum-infected erythrocytes via the DBL1alpha domain of PfEMP1. Blood 101 (2003) 2405-2411
26. Yanagi Y., Ono N., Tatsuo H., Hashimoto K., and Minagawa H. Measles virus receptor SLAM (CD150). Virology 299 (2002) 155-161